Clinical Trial

COLLISION RELAPSE Trial

Name: COLLISION RELAPSE Trial — clinical trial record (NCT05861505)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary objective is to demonstrate superiority of neoadjuvant systemic therapy followed by repeat local treatment as compared to upfront repeat local treatment in patients with at least one locally treatable recurrent CRLM in the absence of extrahepatic disease.

Trial Details

NCT Number	NCT05861505
Lead Sponsor	Amsterdam UMC, location VUmc
Conditions	Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer, Chemotherapy Effect, Surgery, Recurrence
Enrollment	360 participants
Start Date	2023-04-24
Primary Completion	2027-05-01 (estimated)
Study Completion	2028-05-01 (estimated)
Updated on ClinicalTrials.gov	2023-05-17